The forecast for calcium channel blocking medicine sales in Italy from 2024 to 2028 indicates a consistent decline, with sales starting at $278.5 million in 2024 and decreasing steadily to $270.4 million by 2028. This represents a compound annual growth rate (CAGR) of -0.74%. This downward trend suggests a gradual reduction in sales, potentially due to factors like market saturation or increased competition and generic alternatives.

Future trends to watch for include:

Emergence of new therapies or drug classes that could replace or reduce the reliance on calcium channel blockers.
Changes in healthcare policies impacting pricing and accessibility of these medications.
Demographic shifts and varying rates of chronic diseases that may alter demand.